Search - tctmd.com

Displaying 221 - 240 of 260

Sort: Relevancy | Date

Presentation TCT 2012

Screening and Enrollment(2)

Presenter: George Dangas

October 22, 2012

Presentation TCT 2012

PCI in Acute Coronary Syndromes and NSTEMI: Guidelines, Strategies and Outcomes

Presenter: George Dangas

October 22, 2012

News Daily News

Meta-analysis: Mortality Rates Eventually Converge for EVAR, Surgical AAA Repair

Jason Kahn

October 17, 2012

News Daily News

Meta Análisis: Los Índices de Mortalidad Convergen Finalmente para la EVAR y la Reparación Quirúrgica del AAA

Jason Kahn

October 17, 2012

Presentation

Open vs. Endovascular Stent Graft Repair of AAA:A Meta-analysis of Randomized Trials

Presenter: 62622|George Dangas

October 15, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

July 05, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

News Daily News

HORIZONS-AMI: Más Consecuencias Cuando la Trombosis del Stent es Intrahospitalaria

May 09, 2012

Presentation

Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital vs. Out-of-Hospital

Presenter: George D. Dangas

May 07, 2012

Presentation TCT Mediterranean 2012

Safety Issues with Bifurcation Lesions

Presenter: George D. Dangas

May 04, 2012

Presentation TCT Mediterranean 2012

Adjunct Pharmacology for High-Risk PCI

Presenter: George D. Dangas

May 04, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Presentation Fellows 2012

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

Presenter: George Dangas

April 21, 2012

Presentation GI2 2012

New Agents and Prevention of Contrast Induced Nephropathy

Presenter: George Dangas

April 12, 2012

Presentation GI2 2012

ST-Elevation MI: “Bottom Line” Recommendations for Patients At High Risk For Bleeding

Presenter: George D. Dangas

April 11, 2012

Presentation GI2 2012

Left Main Disease Technical Aspects

Presenter: George Dangas

April 11, 2012

News Daily News

El Tratamiento Agresivo con Estatinas Reduce la Carga Lipídica de las Lesiones Obstructivas

April 05, 2012

News Daily News

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

April 05, 2012

News Conference News ACC 2012

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

March 25, 2012

Advertisement

Screening and Enrollment(2)

PCI in Acute Coronary Syndromes and NSTEMI: Guidelines, Strategies and Outcomes

Meta-analysis: Mortality Rates Eventually Converge for EVAR, Surgical AAA Repair

Meta Análisis: Los Índices de Mortalidad Convergen Finalmente para la EVAR y la Reparación Quirúrgica del AAA

Open vs. Endovascular Stent Graft Repair of AAA:A Meta-analysis of Randomized Trials

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

HORIZONS-AMI: Más Consecuencias Cuando la Trombosis del Stent es Intrahospitalaria

Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital vs. Out-of-Hospital

Safety Issues with Bifurcation Lesions

Adjunct Pharmacology for High-Risk PCI

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

New Agents and Prevention of Contrast Induced Nephropathy

ST-Elevation MI: “Bottom Line” Recommendations for Patients At High Risk For Bleeding

Left Main Disease Technical Aspects

El Tratamiento Agresivo con Estatinas Reduce la Carga Lipídica de las Lesiones Obstructivas

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content